Streetbeat News

Earnings

PRGO

Perrigo Company plc (PRGO) reported a Q2 earnings beat, leading to a rise in its share price.

Portfolio Pulse from Bill Haddad

August 08, 2023 | 5:08 pm

IRWD

Ironwood Pharmaceuticals reported its Q2 financial results and issued FY23 revenue guidance, which led to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:07 pm

NPO

EnPro Industries' shares are trading lower despite the company reporting better than expected Q2 earnings.

Portfolio Pulse from Bill Haddad

August 08, 2023 | 5:06 pm

EXPD

Expeditors International of Washington Inc reported a 51% Y/Y decline in Q2 revenue to $2.24 billion, missing the consensus of $2.88 billion. Airfreight tonnage volume and ocean container volume declined 15% and 13% Y/Y respectively. Operating income fell 51% Y/Y to $248.5 million and EPS of $1.30, down 43% Y/Y, missed the consensus of $1.34. The company returned $1 billion to shareholders through share repurchase and dividend payments in H1 2023. Operating cash flow decreased to $158.4 million from $558.6 million a year ago. The company plans to manage down its headcount to align costs with lower levels of demand.

Portfolio Pulse from Lekha Gupta

August 08, 2023 | 5:06 pm

PAYO

Payoneer Global reported better-than-expected Q2 financial results and issued FY23 revenue guidance above estimates, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:05 pm

FOLD

Amicus Therapeutics reported a Q2 revenue beat, leading to a rise in its share prices.

Portfolio Pulse from Bill Haddad

August 08, 2023 | 5:05 pm

WMK

Weis Markets reported a year-over-year increase in Q2 revenue results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 5:04 pm

MCRB

Seres Therapeutics reported Q2 revenues of $126.47 million, beating estimates. The company's net income was $46.6 million, primarily due to the $125 million milestone received upon FDA approval of VOWST. However, EPS of $0.36 missed the analyst consensus. The company plans to announce an additional microbiome therapeutic program in H2 2023. VOWST, the first FDA-approved orally administered microbiome therapeutic, saw broad early demand with 610 completed prescription enrollment forms received.

Portfolio Pulse from Nabaparna Bhattacharya

August 08, 2023 | 5:03 pm

BWAY

BrainsWay (NASDAQ:BWAY) is set to release its latest quarterly earnings report on August 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.17. The company's past performance shows a pattern of missing EPS estimates but still experiencing a slight increase in share price. The stock is currently trading at $2.33, down 59.79% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 5:02 pm

SDOT

Sadot Group (NASDAQ:SDOT) is set to release its latest quarterly earnings report on Wednesday, 2023-08-09. Analysts estimate an earnings per share (EPS) of $-0.02. The company's past performance shows a mix of positive and negative price changes post-earnings release. The stock is currently trading at $1.18 and has seen a 170.79% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 5:02 pm